Patent · US Active

Allergen-specific antibodies

US11434282B2 · kind B2 · utility

1Cited by
3References
7Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 17, 2021
Grant dateSep 6, 2022
Priority date
Expiry dateJun 17, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

In one aspect, methods of generating human monoclonal antibodies that specifically binds to an allergen are provided. In some embodiments, the monoclonal antibodies are generated from sequences identified from isolated single B cells from a human subject who is allergic to the allergen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.